AbbVie Director Thomas C. Freyman Receives 1,118 Restricted Stock Units

This SEC Form 4 filing reports that Thomas C. Freyman, a director of AbbVie Inc. (ABBV), received 1,118 restricted stock units (RSUs) on May 8, 2026. The RSUs were awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program and will convert to common stock on a one-to-one basis upon the earlier of the director's separation from service, death, or a change in control. Following this transaction, Freyman's direct holdings increased to 127,869 shares. The filing also discloses indirect holdings through family trusts, including 4,000 shares held in a revocable trust by his spouse and 3,882 shares (in two separate trusts of 1,941 shares each) held in irrevocable trusts for his son. Freyman disclaims beneficial ownership of these indirect holdings. The filing was signed on May 12, 2026, by T.O. Odutayo as attorney-in-fact for Thomas C. Freyman.